APO Research
Talk to an analyst

APO RESEARCH · REPORT

Softgel CDMO

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Softgel CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

12 August 2026194 pages

Choose your research edition.

Industry ResearchSoftgel CDMO Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Softgel CDMO Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Softgel CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Softgel CDMO Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Softgel CDMO Market Analysis and Forecast 2026-2032173 pages · $4,950 USD

Market perspective

The global Softgel CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Softgel CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Softgel CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Softgel CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Softgel CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Softgel CDMO include Procaps, Patheon, NextPharma, Lonza, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics and Siegfried, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Softgel CDMO market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Softgel CDMO and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Softgel CDMO revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Softgel CDMO market size, projected growth trends, production technologies, key applications, and end-use industries.

Softgel CDMO Segment by Company

Procaps

Patheon

NextPharma

Lonza

Samsung Biologics

Fareva

WuXi AppTech

WuXi Biologics

Siegfried

Catalent

Aenova

Sirio Pharma

Softgel CDMO Segment by Type

Pharmaceutical Softgel CDMO

Nutraceutical Softgel CDMO

Others

Softgel CDMO Segment by Application

Pharmaceutical Company

Biotechnology Company

Others

Softgel CDMO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Softgel CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Softgel CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Softgel CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Softgel CDMO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Softgel CDMO industry.

Chapter 3: Detailed analysis of Softgel CDMO companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Softgel CDMOrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Softgel CDMO Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Pharmaceutical Softgel CDMO Table 3. Key Players of Nutraceutical Softgel CDMO Table 4. Key Players of Others Table 4. Global Softgel CDMO Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceutical Company Table 6. Key Players of Biotechnology Company Table 7. Key Players of Others Table 8. Global Softgel CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Softgel CDMO Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Softgel CDMO Market Share by Region (2021-2026) Table 11. Global Softgel CDMO Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Softgel CDMO Market Share by Region (2027-2032) Table 13. Softgel CDMO Industry Trends Table 14. Softgel CDMO Industry Drivers Table 15. Softgel CDMO Industry Opportunities and Challenges Table 16. Softgel CDMO Industry Restraints Table 17. Global Softgel CDMO Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Softgel CDMO Revenue Market Share by Company (2021-2026) Table 19. Global Softgel CDMO Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Softgel CDMO Key Company Head Office and Area Served Table 21. Global Softgel CDMO Company, Product Type & Application Table 22. Global Softgel CDMO Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Softgel CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Softgel CDMO Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Softgel CDMO Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Softgel CDMO Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Softgel CDMO Revenue Market Share by Type (2021-2026) Table 29. Global Softgel CDMO Revenue Market Share by Type (2027-2032) Table 30. Global Softgel CDMO Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Softgel CDMO Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Softgel CDMO Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Softgel CDMO Revenue Market Share by Application (2021-2026) Table 34. Global Softgel CDMO Revenue Market Share by Application (2027-2032) Table 35. Procaps Company Information Table 36. Procaps Business Overview Table 37. Procaps Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Procaps Softgel CDMO Product Portfolio Table 39. Procaps Recent Development Table 40. Patheon Company Information Table 41. Patheon Business Overview Table 42. Patheon Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Patheon Softgel CDMO Product Portfolio Table 44. Patheon Recent Development Table 45. NextPharma Company Information Table 46. NextPharma Business Overview Table 47. NextPharma Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. NextPharma Softgel CDMO Product Portfolio Table 49. NextPharma Recent Development Table 50. Lonza Company Information Table 51. Lonza Business Overview Table 52. Lonza Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Lonza Softgel CDMO Product Portfolio Table 54. Lonza Recent Development Table 55. Samsung Biologics Company Information Table 56. Samsung Biologics Business Overview Table 57. Samsung Biologics Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Samsung Biologics Softgel CDMO Product Portfolio Table 59. Samsung Biologics Recent Development Table 60. Fareva Company Information Table 61. Fareva Business Overview Table 62. Fareva Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Fareva Softgel CDMO Product Portfolio Table 64. Fareva Recent Development Table 65. WuXi AppTech Company Information Table 66. WuXi AppTech Business Overview Table 67. WuXi AppTech Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. WuXi AppTech Softgel CDMO Product Portfolio Table 69. WuXi AppTech Recent Development Table 70. WuXi Biologics Company Information Table 71. WuXi Biologics Business Overview Table 72. WuXi Biologics Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. WuXi Biologics Softgel CDMO Product Portfolio Table 74. WuXi Biologics Recent Development Table 75. Siegfried Company Information Table 76. Siegfried Business Overview Table 77. Siegfried Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Siegfried Softgel CDMO Product Portfolio Table 79. Siegfried Recent Development Table 80. Catalent Company Information Table 81. Catalent Business Overview Table 82. Catalent Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Catalent Softgel CDMO Product Portfolio Table 84. Catalent Recent Development Table 85. Aenova Company Information Table 86. Aenova Business Overview Table 87. Aenova Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Aenova Softgel CDMO Product Portfolio Table 89. Aenova Recent Development Table 90. Sirio Pharma Company Information Table 91. Sirio Pharma Business Overview Table 92. Sirio Pharma Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Sirio Pharma Softgel CDMO Product Portfolio Table 94. Sirio Pharma Recent Development Table 95. North America Softgel CDMO Market Size by Type (2021-2026) & (US$ Million) Table 96. North America Softgel CDMO Market Size by Type (2027-2032) & (US$ Million) Table 97. North America Softgel CDMO Market Size by Application (2021-2026) & (US$ Million) Table 98. North America Softgel CDMO Market Size by Application (2027-2032) & (US$ Million) Table 99. North America Softgel CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Softgel CDMO Market Size by Country (2021-2026) Table 101. North America Softgel CDMO Market Size by Country (2027-2032) Table 102. Europe Softgel CDMO Market Size by Type (2021-2026) & (US$ Million) Table 103. Europe Softgel CDMO Market Size by Type (2027-2032) & (US$ Million) Table 104. Europe Softgel CDMO Market Size by Application (2021-2026) & (US$ Million) Table 105. Europe Softgel CDMO Market Size by Application (2027-2032) & (US$ Million) Table 106. Europe Softgel CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Softgel CDMO Market Size by Country (2021-2026) Table 108. Europe Softgel CDMO Market Size by Country (2027-2032) Table 109. China Softgel CDMO Market Size by Type (2021-2026) & (US$ Million) Table 110. China Softgel CDMO Market Size by Type (2027-2032) & (US$ Million) Table 111. China Softgel CDMO Market Size by Application (2021-2026) & (US$ Million) Table 112. China Softgel CDMO Market Size by Application (2027-2032) & (US$ Million) Table 113. Asia Softgel CDMO Market Size by Type (2021-2026) & (US$ Million) Table 114. Asia Softgel CDMO Market Size by Type (2027-2032) & (US$ Million) Table 115. Asia Softgel CDMO Market Size by Application (2021-2026) & (US$ Million) Table 116. Asia Softgel CDMO Market Size by Application (2027-2032) & (US$ Million) Table 117. Asia Softgel CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Softgel CDMO Market Size by Country (2021-2026) Table 119. Asia Softgel CDMO Market Size by Country (2027-2032) Table 120. South America, Middle East & Africa Softgel CDMO Market Size by Type (2021-2026) & (US$ Million) Table 121. South America, Middle East & Africa Softgel CDMO Market Size by Type (2027-2032) & (US$ Million) Table 122. South America, Middle East & Africa Softgel CDMO Market Size by Application (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa Softgel CDMO Market Size by Application (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa Softgel CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. South America, Middle East & Africa Softgel CDMO Market Size by Country (2021-2026) Table 126. South America, Middle East & Africa Softgel CDMO Market Size by Country (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Softgel CDMO Product Image Figure 2. Global Softgel CDMO Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Softgel CDMO Market Share by Type: 2025 VS 2032 Figure 4. Pharmaceutical Softgel CDMO Image Figure 5. Nutraceutical Softgel CDMO Image Figure 6. Others Image Figure 7. Global Softgel CDMO Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Softgel CDMO Market Share by Application: 2025 VS 2032 Figure 9. Pharmaceutical Company Image Figure 10. Biotechnology Company Image Figure 11. Others Image Figure 12. Global Softgel CDMO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 14. Global Softgel CDMO Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Softgel CDMO Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Softgel CDMO Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Softgel CDMO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Softgel CDMO Revenue Market Share by Type (2021-2032) Figure 21. Global Softgel CDMO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Softgel CDMO Revenue Market Share by Application (2021-2032) Figure 23. North America Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 24. North America Softgel CDMO Market Share by Type (2021-2032) Figure 25. North America Softgel CDMO Market Share by Application (2021-2032) Figure 26. North America Softgel CDMO Market Share by Country (2021-2032) Figure 27. United States Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 28. Canada Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 30. Europe Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 31. Europe Softgel CDMO Market Share by Type (2021-2032) Figure 32. Europe Softgel CDMO Market Share by Application (2021-2032) Figure 33. Europe Softgel CDMO Market Share by Country (2021-2032) Figure 34. Germany Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 35. France Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 37. Italy Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 38. Russia Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 40. China Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 41. China Softgel CDMO Market Share by Type (2021-2032) Figure 42. China Softgel CDMO Market Share by Application (2021-2032) Figure 43. Asia Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 44. Asia Softgel CDMO Market Share by Type (2021-2032) Figure 45. Asia Softgel CDMO Market Share by Application (2021-2032) Figure 46. Asia Softgel CDMO Market Share by Country (2021-2032) Figure 47. Japan Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 51. India Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 52. Australia Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Softgel CDMO Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Softgel CDMO Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Softgel CDMO Market Share by Country (2021-2032) Figure 57. Brazil Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 62. UAE Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 64. Chile Softgel CDMO Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceutical Softgel CDMO
  • Nutraceutical Softgel CDMO
  • Others
Applications
  • Pharmaceutical Company
  • Biotechnology Company
  • Others
Companies covered
  • Procaps
  • Patheon
  • NextPharma
  • Lonza
  • Samsung Biologics
  • Fareva
  • WuXi AppTech
  • WuXi Biologics
  • Siegfried
  • Catalent
  • Aenova
  • Sirio Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Softgel CDMO Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Pharmaceutical Softgel CDMO
  5. 1.2.3 Nutraceutical Softgel CDMO
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Softgel CDMO Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmaceutical Company
  10. 1.3.3 Biotechnology Company
  11. 1.3.4 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Softgel CDMO Growth Trends by Region
  14. 1.5.1 Global Softgel CDMO Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Softgel CDMO Market Size by Region (2021-2026)
  16. 1.5.3 Softgel CDMO Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Softgel CDMO Market Dynamics
  1. 2.1 Softgel CDMO Industry Trends
  2. 2.2 Softgel CDMO Industry Drivers
  3. 2.3 Softgel CDMO Industry Opportunities and Challenges
  4. 2.4 Softgel CDMO Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Softgel CDMO Revenue by Company (2021-2026)
  2. 3.2 Global Softgel CDMO Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Softgel CDMO Key Company Head office and Area Served
  4. 3.4 Global Softgel CDMO Company, Product Type & Application
  5. 3.5 Global Softgel CDMO Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Softgel CDMO Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Softgel CDMO Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Softgel CDMO Tier 1, Tier 2, and Tier 3
4 Softgel CDMO Market by Type
  1. 4.1 Global Softgel CDMO Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Softgel CDMO Market Size by Type (2021-2032)
  3. 4.3 Global Softgel CDMO Market Size Share by Type (2021-2032)
5 Softgel CDMO Market by Application
  1. 5.1 Global Softgel CDMO Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Softgel CDMO Market Size by Application (2021-2032)
  3. 5.3 Global Softgel CDMO Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Procaps
  2. 6.1.1 Procaps Company Information
  3. 6.1.2 Procaps Business Overview
  4. 6.1.3 Procaps Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Procaps Softgel CDMO Product Portfolio
  6. 6.1.5 Procaps Recent Developments
  7. 6.2 Patheon
  8. 6.2.1 Patheon Company Information
  9. 6.2.2 Patheon Business Overview
  10. 6.2.3 Patheon Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Patheon Softgel CDMO Product Portfolio
  12. 6.2.5 Patheon Recent Developments
  13. 6.3 NextPharma
  14. 6.3.1 NextPharma Company Information
  15. 6.3.2 NextPharma Business Overview
  16. 6.3.3 NextPharma Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 NextPharma Softgel CDMO Product Portfolio
  18. 6.3.5 NextPharma Recent Developments
  19. 6.4 Lonza
  20. 6.4.1 Lonza Company Information
  21. 6.4.2 Lonza Business Overview
  22. 6.4.3 Lonza Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Lonza Softgel CDMO Product Portfolio
  24. 6.4.5 Lonza Recent Developments
  25. 6.5 Samsung Biologics
  26. 6.5.1 Samsung Biologics Company Information
  27. 6.5.2 Samsung Biologics Business Overview
  28. 6.5.3 Samsung Biologics Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Samsung Biologics Softgel CDMO Product Portfolio
  30. 6.5.5 Samsung Biologics Recent Developments
  31. 6.6 Fareva
  32. 6.6.1 Fareva Company Information
  33. 6.6.2 Fareva Business Overview
  34. 6.6.3 Fareva Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Fareva Softgel CDMO Product Portfolio
  36. 6.6.5 Fareva Recent Developments
  37. 6.7 WuXi AppTech
  38. 6.7.1 WuXi AppTech Company Information
  39. 6.7.2 WuXi AppTech Business Overview
  40. 6.7.3 WuXi AppTech Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 WuXi AppTech Softgel CDMO Product Portfolio
  42. 6.7.5 WuXi AppTech Recent Developments
  43. 6.8 WuXi Biologics
  44. 6.8.1 WuXi Biologics Company Information
  45. 6.8.2 WuXi Biologics Business Overview
  46. 6.8.3 WuXi Biologics Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 WuXi Biologics Softgel CDMO Product Portfolio
  48. 6.8.5 WuXi Biologics Recent Developments
  49. 6.9 Siegfried
  50. 6.9.1 Siegfried Company Information
  51. 6.9.2 Siegfried Business Overview
  52. 6.9.3 Siegfried Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Siegfried Softgel CDMO Product Portfolio
  54. 6.9.5 Siegfried Recent Developments
  55. 6.10 Catalent
  56. 6.10.1 Catalent Company Information
  57. 6.10.2 Catalent Business Overview
  58. 6.10.3 Catalent Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Catalent Softgel CDMO Product Portfolio
  60. 6.10.5 Catalent Recent Developments
  61. 6.11 Aenova
  62. 6.11.1 Aenova Company Information
  63. 6.11.2 Aenova Business Overview
  64. 6.11.3 Aenova Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Aenova Softgel CDMO Product Portfolio
  66. 6.11.5 Aenova Recent Developments
  67. 6.12 Sirio Pharma
  68. 6.12.1 Sirio Pharma Company Information
  69. 6.12.2 Sirio Pharma Business Overview
  70. 6.12.3 Sirio Pharma Softgel CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Sirio Pharma Softgel CDMO Product Portfolio
  72. 6.12.5 Sirio Pharma Recent Developments
7 North America
  1. 7.1 North America Softgel CDMO Market Size (2021-2032)
  2. 7.2 North America Softgel CDMO Market Size by Type
  3. 7.2.1 North America Softgel CDMO Market Size by Type (2021-2026)
  4. 7.2.2 North America Softgel CDMO Market Size by Type (2027-2032)
  5. 7.2.3 North America Softgel CDMO Market Share by Type (2021-2032)
  6. 7.3 North America Softgel CDMO Market Size by Application
  7. 7.3.1 North America Softgel CDMO Market Size by Application (2021-2026)
  8. 7.3.2 North America Softgel CDMO Market Size by Application (2027-2032)
  9. 7.3.3 North America Softgel CDMO Market Share by Application (2021-2032)
  10. 7.4 North America Softgel CDMO Market Size by Country
  11. 7.4.1 North America Softgel CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Softgel CDMO Market Size by Country (2021-2026)
  13. 7.4.3 North America Softgel CDMO Market Size by Country (2027-2032)
  14. 7.4.4 North America Softgel CDMO Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Softgel CDMO Market Size (2021-2032)
  2. 8.2 Europe Softgel CDMO Market Size by Type
  3. 8.2.1 Europe Softgel CDMO Market Size by Type (2021-2026)
  4. 8.2.2 Europe Softgel CDMO Market Size by Type (2027-2032)
  5. 8.2.3 Europe Softgel CDMO Market Share by Type (2021-2032)
  6. 8.3 Europe Softgel CDMO Market Size by Application
  7. 8.3.1 Europe Softgel CDMO Market Size by Application (2021-2026)
  8. 8.3.2 Europe Softgel CDMO Market Size by Application (2027-2032)
  9. 8.3.3 Europe Softgel CDMO Market Share by Application (2021-2032)
  10. 8.4 Europe Softgel CDMO Market Size by Country
  11. 8.4.1 Europe Softgel CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Softgel CDMO Market Size by Country (2021-2026)
  13. 8.4.3 Europe Softgel CDMO Market Size by Country (2027-2032)
  14. 8.4.4 Europe Softgel CDMO Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Softgel CDMO Market Size (2021-2032)
  2. 9.2 China Softgel CDMO Market Size by Type
  3. 9.2.1 China Softgel CDMO Market Size by Type (2021-2026)
  4. 9.2.2 China Softgel CDMO Market Size by Type (2027-2032)
  5. 9.2.3 China Softgel CDMO Market Share by Type (2021-2032)
  6. 9.3 China Softgel CDMO Market Size by Application
  7. 9.3.1 China Softgel CDMO Market Size by Application (2021-2026)
  8. 9.3.2 China Softgel CDMO Market Size by Application (2027-2032)
  9. 9.3.3 China Softgel CDMO Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Softgel CDMO Market Size (2021-2032)
  2. 10.2 Asia Softgel CDMO Market Size by Type
  3. 10.2.1 Asia Softgel CDMO Market Size by Type (2021-2026)
  4. 10.2.2 Asia Softgel CDMO Market Size by Type (2027-2032)
  5. 10.2.3 Asia Softgel CDMO Market Share by Type (2021-2032)
  6. 10.3 Asia Softgel CDMO Market Size by Application
  7. 10.3.1 Asia Softgel CDMO Market Size by Application (2021-2026)
  8. 10.3.2 Asia Softgel CDMO Market Size by Application (2027-2032)
  9. 10.3.3 Asia Softgel CDMO Market Share by Application (2021-2032)
  10. 10.4 Asia Softgel CDMO Market Size by Country
  11. 10.4.1 Asia Softgel CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Softgel CDMO Market Size by Country (2021-2026)
  13. 10.4.3 Asia Softgel CDMO Market Size by Country (2027-2032)
  14. 10.4.4 Asia Softgel CDMO Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Softgel CDMO Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Softgel CDMO Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Softgel CDMO Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Softgel CDMO Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Softgel CDMO Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Softgel CDMO Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Softgel CDMO Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Softgel CDMO Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Softgel CDMO Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Softgel CDMO Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Softgel CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Softgel CDMO Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Softgel CDMO Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Softgel CDMO Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst